Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Port Macquarie
Clinical trial register · Australia

Clinical Trials in Port Macquarie, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3378 matching records held by the registry are in this view. Synced 14 Nov 2026, 03:19 UTC
3378
Studies in scope
all four open statuses
1824
Recruiting now
open to new participants
781
Lead sponsors
across recruiting studies
Top sites
Melbourne 1113 Adelaide 582 Sydney 522 Westmead 422 Clayton 413
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca6 Merck Sharp & Dohme LLC4 AbbVie3 Exelixis3 Amgen2 BeOne Medicines2 Pfizer2 University of Sydney2 Bristol-Myers Squibb2 Australian and New Zealand Intensive Care Research Centre1 Melanoma and Skin Cancer Trials Limited1 Omico1 Mirati Therapeutics Inc.1 Aragon Pharmaceuticals, Inc.1 Janssen Research & Development, LLC1 GlaxoSmithKline1 Novartis Pharmaceuticals1 The University of Queensland1 Kahr Bio Australia Pty Ltd1 Gilead Sciences1 Celgene1 Hoffmann-La Roche1 Boehringer Ingelheim1 Incyte Corporation1
Site location
Melbourne1113 Adelaide582 Sydney522 Westmead422 Clayton413 Nedlands383 Brisbane356 Camperdown350 Parkville320 South Brisbane314 Perth299 Heidelberg274 Darlinghurst246 Woolloongabba239 Randwick210 St Leonards199 Liverpool196 Murdoch190 Fitzroy177 Kogarah162 Box Hill156 Bedford Park154 Southport154 Wollongong149 Herston147 Show all 397
All 397 locations
Target enrolment
to

Trials with a site in Port Macquarie

41 of 3378 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
AstraZeneca
Phase 3
950
Auchenflower, Benowa, Hobart, Kingswood, Nedlands, Port Macquarie, Randwick, Richmond
2026-09-16
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
NCT07652658Idiopathic Pulmonary Fibrosis (IPF)
AstraZeneca
Phase 2
359
Camperdown, Port Macquarie, Wollongong
2026-06-11
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Darlinghurst, Garran, Heidelberg, Macquarie University, Melbourne, Perth, Port Macquarie
2026-05-31
Recruiting
Incyte Corporation
Phase 3
700
Port Macquarie, Randwick, Waratah, Westmead, Wollongong, Southport, Townsville, Woolloongabba
2026-03-05
Recruiting
Kahr Bio Australia Pty Ltd
Phase 2
90
Woodville, Camperdown, Port Macquarie, Westmead, South Brisbane, Bedford Park, Clayton, Footscray
2026-01-16
Recruiting
AbbVie
Phase 1/2
602
Coffs Harbour, Port Macquarie, Westmead, South Brisbane, Adelaide, Fitzroy, Melbourne, West Perth
2025-06-30
Recruiting
Perioperative Durvalumab With Neoadjuvant ddMVAC in Patients With Muscle-Invasive Bladder Cancer (NIAGARA-2)
NCT06960577Urinary Bladder Neoplasms, Immune Checkpoint Inhibitors, Methotrexate, Vinblastine
DrugsVinblastine·Methotrexate·Doxorubicin·Durvalumab
AstraZeneca
Phase 2
150
Chermside, Elizabeth Vale, Heidelberg, Hong Kong, Kogarah, Macquarie University, Murdoch, Port Macquarie
2025-05-15
Recruiting
BeOne Medicines
Phase 3
250
Concord, Gosford, Port Macquarie, Randwick, Toowoomba, Bedford PK, Melbourne, West Perth
2025-04-10
Active, closed
Celgene
Phase 3
960
Campbelltown, Darlinghurst, Macquarie University, Port Macquarie, Wahroonga, Greenslopes, Southport, Adelaide
2025-03-13
Active, closed
Boehringer Ingelheim
Phase 3
8,371
Concord, Gosford, Kingswood, Kogarah, Liverpool, Port Macquarie, Pialba, Southport
2024-08-30
Active, closed
Exelixis
Phase 2/3
600
Port Macquarie, Adelaide, Bedford Park, Camperdown, Murdoch
2024-06-07
Recruiting
AstraZeneca
Phase 3
5,250
Birtinya, Cairns, Chermside, Coffs Harbour, Dubbo, Nedlands, Port Macquarie, Spearwood
2024-02-21
Active, closed
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
NCT06117774Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer
DrugTarlatamab
Amgen
Phase 3
404
Port Macquarie, Westmead, Bedford Park, Clayton, Murdoch
2024-02-20
Active, closed
Merck Sharp & Dohme LLC
Phase 2
147
Port Macquarie, Frankston
2023-12-26
Active, closed
Omico
Phase 2
96
Albury, Coffs Harbour, Orange, Port Macquarie, Cairns, Toowoomba, Townsville, Hobart
2023-12-15
Recruiting
Merck Sharp & Dohme LLC
Phase 3
614
Port Macquarie, Westmead, Ballarat Central, Epping, Frankston
2023-12-15
Recruiting
Amgen
Phase 3
750
Campbelltown, Concord, Kingswood, Port Macquarie, St Leonards, Waratah, Toowoomba, Woolloongabba
2023-11-16
Active, closed
Bristol-Myers Squibb
Phase 3
579
Coffs Harbour, Orange, Port Macquarie, Wagga Wagga, Waratah, Westmead, Wollstonecraft, Birtinya
2023-03-06
Active, closed
Bristol-Myers Squibb
Phase 3
606
Camperdown, Gosford, Port Macquarie, St Leonards, Sydney, Adelaide, Bendigo, East Melbourne
2023-01-10
Recruiting
AstraZeneca
Phase 3
3,527
Adelaide, Bedford Park, New Lambton Heights, Port Macquarie, South Brisbane
2022-12-13
Recruiting
Gilead Sciences
Phase 3
1,514
Campbelltown, Darlinghurst, Gateshead, Port Macquarie, Cairns, Douglass, Woolloongabba, Adelaide
2022-12-12
Active, closed
Exelixis
Phase 3
901
Albury, Bankstown, Bedford Park, Heidelberg, Melbourne, Port Macquarie, Woodville South
2022-09-07
Recruiting
The University of Queensland
Not applicable
372
Concord, Frenchs Forest, Kogarah, Liverpool, New Lambton Heights, Port Macquarie, Saint Leonards, Bundaberg
2022-07-06
Recruiting
AbbVie
Phase 3
768
Port Macquarie, Westmead, Geelong, Heidelberg
2022-03-25
Active, closed
BeOne Medicines
Phase 3
799
Concord, Gosford, Kogarah, Orange, Port Macquarie, Westmead, Douglas, North Adelaide
2022-03-10
Active, closed
Australian and New Zealand Intensive Care Research Centre
Phase 3
1,000
Bankstown, Camperdown, Kingswood, New Lambton Heights, Port Macquarie, Sydney, Tamworth, Westmead
2021-10-26
Active, closed
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
NCT04971226Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
DrugsBosutinib·Asciminib·ABL001·Nilotinib
Novartis Pharmaceuticals
Phase 3
405
Kingswood, Port Macquarie, Adelaide, Southport
2021-10-06
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Albury, Campbelltown, Liverpool, Northmead, Port Macquarie, Wollstonecraft, Auchenflower, Brisbane
2021-08-27
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Ballarat, Bedford Park, Clayton, Garran, Hyde Park, Port Macquarie, Wollongong, Woolloongabba
2020-12-02
Active, closed
Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma
NCT04291885Merkel Cell Carcinoma, Merkel Cell Carcinoma, Stage I, Merkel Cell Carcinoma, Stage II, Merkel Cell Carcinoma, Stage III
DrugAvelumab
Melanoma and Skin Cancer Trials Limited
Phase 2
122
Port Macquarie, Sydney, Wollongong, Brisbane, Bundaberg, Cairns, Hervey Bay, Mackay
2020-10-26
Active, closed
Exelixis
Phase 3
575
Garran, Port Macquarie, Saint Leonards, Sydney, Wollongong, Chermside, Launceston, Ballarat
2020-10-19
Active, closed
GlaxoSmithKline
Phase 3
302
Garran, Darlinghurst, Gosford NSW, Port Macquarie, Benowa, South Brisbane, Adelaide, Fitzroy
2020-10-01
Active, closed
AbbVie
Phase 3
531
Blacktown, Kogarah, Port Macquarie, Southport, Adelaide, Fitzroy Melbourne, Heidelberg
2020-09-10
Active, closed
Merck Sharp & Dohme LLC
Phase 2
329
Darlinghurst, Port Macquarie, Nedlands
2018-12-12
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
Camperdown, Liverpool, Macquarie University, North Sydney, Orange, Port Macquarie, St Leonards, Waratah
2018-08-21
Active, closed
University of Sydney
Phase 2
103
Campbelltown, Camperdown, Gosford, New Lambton Heights, Port Macquarie, Randwick, Saint Leonards, Wollongong
2018-02-22
Active, closed
Pfizer
Phase 3
1,054
Camperdown, Darlinghurst, Port Macquarie, Auchenflower, Brisbane, Chermside, South Brisbane, Southport
2017-12-18
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,052
Albury, Elizabeth Vale, Kogarah, Port Macquarie, South Brisbane, St Leonards
2015-11-27
Active, closed
AstraZeneca
Phase 3
1,118
Box Hill, Gosford, Kogarah, Melbourne, Port Macquarie, Southport, St Leonards
2015-07-21
Active, closed
Pfizer
Phase 3
1,068
Gateshead, Lismore, Liverpool, North Ryde, North Sydney, Port Macquarie, St Leonards, Tweed Heads
2014-12-17
Active, closed
University of Sydney
Phase 3
1,125
Camperdown, Coffs Harbour, Concord, Darlinghurst, Kingswood, Kogarah, Orange, Port Macquarie
2014-03
Rows per page Showing 1–41 of 41
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 November 2026. https://priyalifescience.com/clinical-trials-australia/city/port-macquarie

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,378 studies in total at the last sync on 14 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 41 of those studies with a site in Port Macquarie.

How many clinical trials are recruiting in Port Macquarie?

17 of the 41 studies on this page are recruiting new participants as of the 14 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 24 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Port Macquarie), 41 studies
PhaseStudiesRecruitingShare
Phase 3291170.7%
Phase 28319.5%
Phase 2/3214.9%
Not applicable112.4%
Phase 1/2112.4%

Most active sponsors

Lead sponsors with the most studies (Port Macquarie)
Lead sponsorStudiesRecruiting
AstraZeneca65
Merck Sharp & Dohme LLC42
AbbVie32
Exelixis30
Amgen21
BeOne Medicines21
Bristol-Myers Squibb20
Pfizer20
University of Sydney20
Aragon Pharmaceuticals, Inc.10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.